46 related articles for article (PubMed ID: 20372850)
1. Therapeutic potential of the dual-targeted TAS-102 formulation in the treatment of gastrointestinal malignancies.
Temmink OH; Emura T; de Bruin M; Fukushima M; Peters GJ
Cancer Sci; 2007 Jun; 98(6):779-89. PubMed ID: 17441963
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies.
Peters GJ
Ther Adv Med Oncol; 2015 Nov; 7(6):340-56. PubMed ID: 26557901
[TBL] [Abstract][Full Text] [Related]
3. Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models.
Tanaka N; Sakamoto K; Okabe H; Fujioka A; Yamamura K; Nakagawa F; Nagase H; Yokogawa T; Oguchi K; Ishida K; Osada A; Kazuno H; Yamada Y; Matsuo K
Oncol Rep; 2014 Dec; 32(6):2319-26. PubMed ID: 25230742
[TBL] [Abstract][Full Text] [Related]
4. Serum thymidine kinase 1 is associated with Gleason score of patients with prostate carcinoma.
Li S; Zhou J; Wang Y; Zhang K; Yang J; Zhang X; Wang C; Ma H; Zhou J; He E; Skog S
Oncol Lett; 2018 Nov; 16(5):6171-6180. PubMed ID: 30333882
[TBL] [Abstract][Full Text] [Related]
5. TAS-102 has a tumoricidal activity in multiple myeloma.
Li G; Liu H; He J; Li Z; Wang Z; Zhou S; Zheng G; He Z; Yang J
Am J Cancer Res; 2020; 10(11):3752-3764. PubMed ID: 33294265
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Thymidylate Synthase Expression in Prostate Cancer.
Ohta S; Kamoshida S; Tashiro A; O-Ono KI; Yasuno N; Kamakura Y; Yasuda M
Curr Urol; 2015 Dec; 8(4):194-198. PubMed ID: 30263026
[TBL] [Abstract][Full Text] [Related]
7. Emerging combination therapies for metastatic colorectal cancer - impact of trifluridine/tipiracil.
Puthiamadathil JM; Weinberg BA
Cancer Manag Res; 2017; 9():461-469. PubMed ID: 29056855
[TBL] [Abstract][Full Text] [Related]
8. High pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase.
Kuo WT; Tu DG; Chiu LY; Sheu GT; Wu MF
Oncol Rep; 2017 Nov; 38(5):2787-2795. PubMed ID: 28901493
[TBL] [Abstract][Full Text] [Related]
9. A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice.
Wang L; Cao M; Wei QL; Zhao ZH; Xiang Q; Wang HJ; Zhang HT; Lai GQ
PLoS One; 2017; 12(4):e0175992. PubMed ID: 28426720
[TBL] [Abstract][Full Text] [Related]
10. Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA.
Sakamoto K; Yokogawa T; Ueno H; Oguchi K; Kazuno H; Ishida K; Tanaka N; Osada A; Yamada Y; Okabe H; Matsuo K
Int J Oncol; 2015; 46(6):2327-34. PubMed ID: 25901475
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity of a thymidine quinoxaline conjugate is modulated by cytosolic thymidine pathways.
Wei Q; Liu H; Zhou H; Zhang D; Zhang Z; Zhou Q
BMC Cancer; 2015 Mar; 15():159. PubMed ID: 25881156
[TBL] [Abstract][Full Text] [Related]
12. The infection efficiency and replication ability of circularized HBV DNA optimized the linear HBV DNA in vitro and in vivo.
Li X; Zhu J; Lai G; Yan L; Hu J; Chen J; Tang N; Huang A
Int J Mol Sci; 2015 Mar; 16(3):5141-60. PubMed ID: 25751726
[TBL] [Abstract][Full Text] [Related]
13. Thymidine kinase 1 as a diagnostic tumor marker is of moderate value in cancer patients: A meta-analysis.
Xiang Y; Zeng H; Liu X; Zhou H; Luo L; Duan C; Luo X; Yan H
Biomed Rep; 2013 Jul; 1(4):629-637. PubMed ID: 24648999
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical characterization of pyrimidine synthetic enzymes, thymidine kinase-1 and thymidylate synthase, in various types of cancer.
Shintani M; Urano M; Takakuwa Y; Kuroda M; Kamoshida S
Oncol Rep; 2010 May; 23(5):1345-50. PubMed ID: 20372850
[TBL] [Abstract][Full Text] [Related]
15. Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse model.
Emura T; Nakagawa F; Fujioka A; Ohshimo H; Kitazato K
Oncol Rep; 2004 Feb; 11(2):381-7. PubMed ID: 14719072
[TBL] [Abstract][Full Text] [Related]
16. Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy.
Foekens JA; Romain S; Look MP; Martin PM; Klijn JG
Cancer Res; 2001 Feb; 61(4):1421-5. PubMed ID: 11245445
[TBL] [Abstract][Full Text] [Related]
17. [Effects of neo-adjuvant chemotherapy with UFT (a combination of tegafur and uracil) on DNA-synthesizing enzyme activities in human colorectal carcinomas].
Sakamoto S; Kudo H; Kuwa K; Kawasaki T; Kasahara N; Okamoto R; Sagara T; Kawachi Y; Iwama T; Hirayama R
Nihon Gan Chiryo Gakkai Shi; 1989 Jan; 24(1):94-8. PubMed ID: 2500492
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase expression and prognosis of patients with gastrointestinal cancers receiving adjuvant chemotherapy: a review.
Formentini A; Henne-Bruns D; Kornmann M
Langenbecks Arch Surg; 2004 Oct; 389(5):405-13. PubMed ID: 15309542
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
